Boehringer Ingelheim· @Boehringer · X·· 2025-12-22AI 评分18
AI 导读
#NEWS：慢性肾脏病影响约十分之一的成年人（约8.5亿人）。我们与@RectifyPharma携手，针对与钙化和心肾风险相关的潜在疾病机制。 了解更多：https://go.boehringer.com/mPnXJ #ResearchCollaboration #CKD
正文
#NEWS: Chronic kidney disease impacts ~1 in 10 adults (~850 million people). Together with @RectifyPharma, we’re targeting underlying disease mechanisms linked to calcification and cardiorenal risk.
Learn more at https://go.boehringer.com/mPnXJ
#ResearchCollaboration #CKD
来源：Boehringer Ingelheim · x.com